Adicet Bio, Inc.
ACET · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $85 | $81 | $367 | $541 |
| - Cash | $56 | $160 | $258 | $278 |
| + Debt | $17 | $21 | $21 | $21 |
| Enterprise Value | $45 | -$57 | $131 | $285 |
| Revenue | $0 | $0 | $25 | $10 |
| % Growth | – | -100% | 156.8% | – |
| Gross Profit | $0 | $0 | $25 | $10 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$111 | -$137 | -$65 | -$60 |
| % Margin | – | – | -258.9% | -620.9% |
| Net Income | -$117 | -$143 | -$70 | -$62 |
| % Margin | – | – | -279.3% | -637.2% |
| EPS Diluted | -1.33 | -3.31 | -1.7 | -2 |
| % Growth | 59.8% | -94.7% | 15% | – |
| Operating Cash Flow | -$92 | -$94 | -$45 | -$51 |
| Capital Expenditures | -$1 | -$4 | -$17 | -$13 |
| Free Cash Flow | -$93 | -$98 | -$62 | -$64 |